Study on Efficacy of Hydroxychloroquine for Treatment of COVID-19
Abstract
Abstract
Corona Virus Disease (COVID-19) case was first registered on 17th November 2019. Since then there has been an up-scale of cases and this pandemic has risen like never before all over the world. Since, this disease has not been seen before, so there has been no proper treatment and proper vaccination for people. Ever since the pandemic started, the researchers and scientists started working for developing vaccine for the treatment of COVID-19. In spite of research being done by scientists and researchers, currently no treatment is specifically approved for COVID-19. Some of the researchers have suggested to use quinine derivatives i.e. hydroxychloroquine (HCQ) and chloroquine as temporary vaccines. The hydroxychloroquine came into the picture due to its occurrence and action during malaria. It is an anti-malaria drug that has helped in past in curing this disease. Use of hydroxychloroquine for treatment of COVID-19 has several issues however, its positive effect outweigh the negative effect that the patient will have. Another issue is if it can be used then whether the world is equipped with so much of stock to cure the rising COVID-19 victims. Many researchers have been working on the efficaciousness of hydroxychloroquine however the effect of hydroxychloroquine is yet to be seen. Also, there has been no clinical evidence for hydroxychloroquine as of now. Efforts are being made to support universal decision of clinic and laboratories for the faster attainment of a vaccine. Besides presenting hypothesis, experimenting and providing a better solution is need of hours. This work is a thorough study on experimental ideas and finding out whether hydroxychloroquine is an effective method of treating corona virus patients.
Keywords: Corona, COVID-19, drug, chloroquine, effect, hydroxychloroquine
Cite this Article
Prathamesh Suresh Kotkar, Anita Kumari. Study on Efficacy of Hydroxychloroquine for Treatment of COVID-19. Research & Reviews: Journal of Medicine. 2020; 10(2): 42–46p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |